NextGen Healthcare Inc. (NXGN)
NASDAQ: NXGN
· Real-Time Price · USD
23.94
0.03 (0.13%)
At close: Nov 08, 2023, 10:00 PM
NextGen Healthcare Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 695.05M | 678.08M | 653.17M | 625.88M | 613.73M | 603.57M | 596.35M | 589.28M | 581.31M | 572.03M | 556.82M | 549.01M | 545M | 539.26M |
Cost of Revenue | 372.56M | 360.35M | 342.01M | 323.74M | 312.6M | 302.72M | 295.4M | 289.42M | 285.54M | 281.8M | 275.42M | 273.98M | 271.79M | 268.58M |
Gross Profit | 322.49M | 317.73M | 311.16M | 302.14M | 301.13M | 300.85M | 300.95M | 299.86M | 295.77M | 290.23M | 281.4M | 275.03M | 273.21M | 270.68M |
Operating Income | 9.68M | 22.41M | 11.37M | 34.35M | 32.79M | 4.11M | 6.66M | 3.56M | -3.52M | 14.67M | 12.82M | 6.82M | 9.17M | 5.6M |
Interest Income | 6.61M | 5.16M | 3.54M | 1.67M | 192K | 135K | 101K | 90K | 49K | 44K | 38K | 138K | 159K | 183K |
Pretax Income | -685K | 11.95M | 4.3M | 31.34M | 30.23M | 2.69M | 5.2M | 1.95M | -5.48M | 11.89M | 9.28M | 4.04M | 6.75M | 4.19M |
Net Income | -6.21M | 2.35M | -2.65M | 22.93M | 20.31M | -82K | 1.62M | 690K | -4.04M | 13.19M | 9.52M | 5.85M | 9.8M | 5.43M |
Selling & General & Admin | 231.87M | 222.58M | 223.42M | 190.14M | 191.2M | 210.21M | 209.66M | 208.49M | 210.22M | 188.28M | 180.53M | 174.82M | 168.69M | 165.78M |
Research & Development | 78.59M | 81.43M | 82.3M | 81.7M | 81.47M | 79.13M | 76.66M | 78.62M | 77.43M | 76.6M | 75.5M | 75.54M | 77.37M | 79.47M |
Other Expenses | 3.87M | 4.15M | 2.96M | 1.6M | 675K | -42K | -64K | -90K | -96K | -102K | -64K | 615K | 767K | 995K |
Operating Expenses | 315.1M | 308.16M | 309.39M | 275.06M | 275.85M | 292.69M | 289.84M | 290.86M | 291.63M | 269.1M | 260.48M | 255.14M | 250.69M | 249.64M |
Interest Expense | 12.19M | 9.21M | 6.3M | 3.44M | 1.52M | 1.51M | 1.5M | 1.6M | 1.91M | 2.73M | 3.52M | 3.53M | 3.34M | 2.59M |
Selling & Marketing Expenses | 10.27M | 10.27M | 10.27M | 6.78M | 6.78M | 6.78M | 6.78M | 3.9M | 3.9M | 3.9M | 3.9M | 6.04M | 6.04M | 6.04M |
Cost & Expenses | 687.66M | 668.51M | 651.4M | 598.8M | 588.45M | 595.41M | 585.25M | 580.28M | 577.18M | 550.89M | 535.9M | 529.13M | 522.49M | 518.22M |
Income Tax Expense | 5.53M | 9.6M | 6.96M | 8.4M | 9.92M | 2.77M | 3.58M | 1.26M | -1.44M | -1.3M | -240K | -1.82M | -3.05M | -1.24M |
Shares Outstanding (Basic) | 67.07M | 66.42M | 66.05M | 66.56M | 67.81M | 67.59M | 66.94M | 67.96M | 67.41M | 67.17M | 67.02M | 66.94M | 66.69M | 66.3M |
Shares Outstanding (Diluted) | 67.69M | 66.85M | 66.05M | 67.31M | 68.42M | 68.28M | 67.6M | 68.17M | 67.41M | 67.8M | 67.59M | 67.14M | 66.69M | 66.3M |
EPS (Basic) | -0.09 | 0.03 | -0.04 | 0.34 | 0.30 | 0.00 | 0.03 | 0.01 | -0.06 | 0.20 | 0.15 | 0.09 | 0.15 | 0.08 |
EPS (Diluted) | -0.1 | 0.03 | -0.04 | 0.34 | 0.30 | 0.00 | 0.03 | 0.01 | -0.06 | 0.20 | 0.15 | 0.09 | 0.15 | 0.08 |
EBITDA | 53.49M | 43.28M | 32.64M | 55.56M | 54.09M | 48.62M | 53.45M | 42.98M | 25.16M | 32.74M | 34.49M | 34M | 36.35M | 31.68M |
EBIT | 11.51M | 21.16M | 10.6M | 34.77M | 31.75M | 4.2M | 6.7M | 3.56M | -3.57M | 14.62M | 12.79M | 7.57M | 10.09M | 6.78M |
Depreciation & Amortization | 41.68M | 41.17M | 41M | 38.61M | 38.7M | 40.41M | 42.36M | 42.95M | 33.32M | 23.91M | 25.84M | 16.68M | 16.53M | 16.29M |